SVCM
ANRO icon

Saturn V Capital Management’s Alto Neuroscience ANRO Stock Holding History

Saturn V Capital Management’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2M Buy
+88,999
New +$1.65M 0.36% 20

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Saturn V Capital Management's ANRO Position: Q1 2026 in Review

Saturn V Capital Management opened a new position in Alto Neuroscience (ANRO) in Q1 2026: 88,999 shares worth $2M. The stake represents 0.36% of the portfolio and ranks #20 among its holdings.

110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.

  • Saturn V Capital Management held 88,999 shares of Alto Neuroscience worth $2M as of Q1 2026.
  • Alto Neuroscience was a new Saturn V Capital Management position in Q1 2026.
  • Alto Neuroscience made up 0.36% of Saturn V Capital Management's portfolio in Q1 2026, its #20 holding.
  • 110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.

Based on Saturn V Capital Management's 13F filing for Q1 2026, filed 15 May 2026.